title: RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells.
abstract: Several evidences support that caveolin-1 is associated with mammary cell transformation and oncogenesis. We have previously reported that a cell line, named MCF10A-ST1 (ST1), which only expressed 30% Cav-1 compared with parental cells MCF10A (human mammary epithelial cell line) was isolated by gene trapping. The decreased expression of Cav-1 is sufficient for phenotypic transformation of MCF10A cells, which involved in the loss of anchorage-dependent growth and migration in nude mice with the existence of E2. The previous study in our lab on microarray assay showed that the expression of cyclin D1 (cell cycle protein) was up-regulated in ST1 cell line. Here, we not only confirmed the results by Western Blot but also demonstrated that Cav-1 down-regulation accelerate the progression of mammary cells from G1 phase into S phase by Flow Cytometry (FCM). This proposed that the Cav-1 down-regulation could change the progress of cell cycle in the mammary cells. Otherwise, microarray assay also showed that the transcription factor (c-Jun) was up-regulated. But, the original carcinoma gene (c-Fos) and transcription factor (AP-1) have not obviously changed compared with MCF10A. ST1 cells obtained the morigenicity in nude mice with the existence of E2, and the immunoprecipitation showed the interactions of Cav-1 with ERα in both MCF10A and ST1. ERα expression was increased as further down-regulation of Cav-1. So, we hypothesize that Cav-1 down-regulation could induce the activation of ERα-associated signaling pathway, in order to adjust the development and proliferation. By siRNA technology, the down regulation of Cav-1 could activate MAP kinase and Akt signaling pathway, including the phosphorylation of ERK1/2 and Akt. However, the mechanism of Cav-1 down-regulation in the early transformation and signaling transduction of mammary epithelial cells is unclear. Here, we report that down-regulation of caveolin-1 protein expression leads to deregulate estrogen receptor alpha (ERα) signaling and consequently early transformation in mammary epithelia.
authors.affiliation: College of Life Science, Liaoning Normal University, 116029, Dalian, China.
authors.forename: Xi
authors.initials: X
authors.lastname: Wang
authors.forename: Shuang
authors.initials: S
authors.lastname: Feng
authors.forename: Hong
authors.initials: H
authors.lastname: Zhang
authors.forename: Yang
authors.initials: Y
authors.lastname: Wang
authors.forename: Yuying
authors.initials: Y
authors.lastname: Cui
authors.forename: Zhaoyi
authors.initials: Z
authors.lastname: Wang
authors.forename: Jing
authors.initials: J
authors.lastname: Liu
authors.forename: Wei
authors.initials: W
authors.lastname: Zou
mesh_terms: D000818:Animals; D051242:Caveolin 1 / Q000096:biosynthesis*; D002460:Cell Line; D045744:Cell Line, Tumor; D002465:Cell Movement; D015536:Down-Regulation; D004847:Epithelial Cells / Q000166:cytology*; D047628:Estrogen Receptor alpha / Q000235:genetics*; D006801:Humans; D042361:Mammary Glands, Human / Q000378:metabolism*; D051379:Mice; D008819:Mice, Nude; D010641:Phenotype; D034622:RNA Interference; D015398:Signal Transduction
chemical_list: D051242:Caveolin 1; D047628:Estrogen Receptor alpha
references.citation: Exp Cell Res. 1999 Nov 25;253(1):255-70
references.pmid: 10579927
references.citation: J Biol Chem. 1998 Aug 7;273(32):20448-55
references.pmid: 9685399
references.citation: Mol Biol Rep. 2008 Mar;35(1):23-7
references.pmid: 17415682
references.citation: Mol Pharmacol. 2009 Aug;76(2):425-39
references.pmid: 19487245
references.citation: J Biol Chem. 1996 Nov 15;271(46):29182-90
references.pmid: 8910575
references.citation: J Endocrinol. 2008 Feb;196(2):385-97
references.pmid: 18252962
references.citation: Proc Natl Acad Sci U S A. 2000 May 23;97(11):5930-5
references.pmid: 10823945
references.citation: Anticancer Res. 2003 Nov-Dec;23(6C):4581-6
references.pmid: 14981899
references.citation: J Cell Physiol. 2001 Mar;186(3):329-37
references.pmid: 11169971
references.citation: BMC Res Notes. 2009 Jul 17;2:140
references.pmid: 19615042
references.citation: FEBS Lett. 1998 Jun 16;429(3):330-6
references.pmid: 9662443
references.citation: Science. 1995 Mar 31;267(5206):2003-6
references.pmid: 7701324
references.citation: Mol Cell Biol. 2000 Jan;20(2):672-83
references.pmid: 10611246
references.citation: J Cell Mol Med. 2008 Jun;12(3):796-809
references.pmid: 18315571
references.citation: J Biol Chem. 1995 Jul 14;270(28):16483-6
references.pmid: 7622446
references.citation: Mol Biol Rep. 2004 Jun;31(2):67-84
references.pmid: 15293782
references.citation: Circulation. 2000 Feb 15;101(6):660-7
references.pmid: 10673259
references.citation: J Cell Physiol. 2001 Aug;188(2):170-7
references.pmid: 11424083
references.citation: Am J Pathol. 2006 Jun;168(6):1998-2013
references.pmid: 16723714
references.citation: Am J Physiol Cell Physiol. 2005 Mar;288(3):C494-506
references.pmid: 15692148
references.citation: Cancer Res. 1996 Mar 1;56(5):1098-1103
references.pmid: 8640767
references.citation: Breast Cancer Res. 2005;7(1):R130-44
references.pmid: 15642162
references.citation: J Cell Biochem. 2005 Oct 15;96(3):490-505
references.pmid: 16092128
references.citation: Breast Cancer Res Treat. 2003 Feb;77(3):265-75
references.pmid: 12602926
references.citation: Endocrinology. 1997 Sep;138(9):4030-3
references.pmid: 9275096
references.citation: Endocr Rev. 2007 Dec;28(7):726-41
references.pmid: 17916740
references.citation: Mol Endocrinol. 2002 Jan;16(1):100-15
references.pmid: 11773442
references.citation: FASEB J. 2002 Jan;16(1):114-6
references.pmid: 11709495
references.citation: Cell. 2001 Jan 12;104(1):21-32
references.pmid: 11163237
references.citation: Pharmacol Rev. 2002 Sep;54(3):431-67
references.pmid: 12223531
references.citation: Int J Cancer. 2000 Aug 15;87(4):468-72
references.pmid: 10918184
references.citation: Mol Endocrinol. 2000 Sep;14(9):1434-47
references.pmid: 10976921
references.citation: Mol Biol Cell. 2005 Jan;16(1):231-7
references.pmid: 15496458